A detailed history of Ophir Asset Management Pty LTD transactions in Care Dx, Inc. stock. As of the latest transaction made, Ophir Asset Management Pty LTD holds 1,892,994 shares of CDNA stock, worth $28.1 Million. This represents 6.05% of its overall portfolio holdings.

Number of Shares
1,892,994
Previous 1,618,369 16.97%
Holding current value
$28.1 Million
Previous $28.7 Million 28.76%
% of portfolio
6.05%
Previous 5.07%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$14.18 - $20.08 $3.89 Million - $5.51 Million
274,625 Added 16.97%
1,892,994 $37 Million
Q1 2025

May 15, 2025

BUY
$17.64 - $25.07 $28.5 Million - $40.6 Million
1,618,369 New
1,618,369 $28.7 Million

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $793M
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Ophir Asset Management Pty LTD Portfolio

Follow Ophir Asset Management Pty LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ophir Asset Management Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Ophir Asset Management Pty LTD with notifications on news.